Back to Search Start Over

A simple colorimetric assay to determine the concentration and proportion of human mercaptalbumin.

Authors :
Tada S
Yasukawa K
Yatomi Y
Uchiki T
Source :
Practical laboratory medicine [Pract Lab Med] 2022 May 23; Vol. 31, pp. e00281. Date of Electronic Publication: 2022 May 23 (Print Publication: 2022).
Publication Year :
2022

Abstract

Objectives: Human serum albumin can take on two forms, mercaptalbumin (HMA) or non-mercaptalbumin (HNA), depending on the redox status of its Cys34. The ratio of HMA and HNA is considered to be a novel biomarker of oxidative stress. While HPLC and mass spectrometry are established methods to measure HMA and HNA, a simple colorimetric assay was applied to measure this biomarker.<br />Design and Methods: Michler's Hydrol (4,4'-Bis(dimethylamino)benzhydrol) is a blue dye with a maximum absorption at 612 nm, and its absorption decreases when it reacts with a thiol group. Concentrations of HMA in serum samples from 36 healthy subjects were measured based on absorption changes of Michler's Hydrol. The proportion of HMA (HMA%) in total albumin was also obtained by dividing the HMA concentration by total albumin concentration, which was obtained by a bromocresol purple (BCP) assay. The proportion of HNA (HNA%) was obtained by subtracting HMA% from 100%.<br />Results: HMA concentrations obtained by Michler's Hydrol assay were highly correlated (r <superscript>2</superscript>  = 0.97) with reference values obtained by HPLC (HMA%) and BCP assay (total albumin). The HNA% obtained by Michler's Hydrol and BCP assays combined also gave a good correlation (r <superscript>2</superscript>  = 0.96) and a small deviation (average 2.4%) with respect to HPLC as a reference method.<br />Conclusions: A colorimetric assay using Michler's Hydrol was optimized for a 96-well plate format so that it can be easily performed in a standard laboratory setting. This assay gives HMA concentrations and HNA proportions comparable to HPLC.<br />Competing Interests: The authors of this article have filed patent applications related to the “corrected analysis” by canceling out the non-thiol components’ contribution to A612 with following details; Methods and kits to measure concentrations of reduced albumin or to determine proportions of reduced and oxidized form of albumin in serum or plasma, Japan Patent Office application No. 2021–178318.<br /> (© 2022 The Authors.)

Details

Language :
English
ISSN :
2352-5517
Volume :
31
Database :
MEDLINE
Journal :
Practical laboratory medicine
Publication Type :
Academic Journal
Accession number :
35711386
Full Text :
https://doi.org/10.1016/j.plabm.2022.e00281